Mink Therapeutics revenue was $0.00 for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was $0.0, down N/A from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, INKT annual revenue was $0.0, with N/A growth year-over-year.
INKT past revenue growth
How has INKT's revenue growth performed historically?
Mink Therapeutics (NASDAQ: INKT) reported Q4 2024 revenue of $0.00 up N/A year over year. In the same quarter last year, Mink Therapeutics's revenue was $0.00.
What was Mink Therapeutics's revenue in 2024?
Mink Therapeutics's annual revenue for the twelve months ending Dec 31, 2024 was $0.00, a N/A decrease year over year.
How much does Mink Therapeutics make in a day?
Based on Mink Therapeutics annual revenue for the past five years, INKT makes an average of $0.00 per day.
What was Mink Therapeutics's annual revenue growth in the past year?
As of Q2 2025, Mink Therapeutics's revenue has grown null year over year. Mink Therapeutics's revenue in the past year totaled $0.00.
How much does Mink Therapeutics make in a year?
Mink Therapeutics's revenue by year for the past five years is:
Mink Therapeutics's revenue for the twelve months ending Dec 31, 2024 was $0.00, a N/A decrease year over year.
Mink Therapeutics's annual revenue for Dec 31, 2023 was $0.00, a N/A decrease from 2022.
Mink Therapeutics's annual revenue for 2022 was $0.00, a N/A decrease from 2021.
Mink Therapeutics's annual revenue for 2021 was $0.00, a N/A decrease from 2020.
Mink Therapeutics's annual revenue for 2020 was $0.00, a 100% decrease from 2019.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.